Skip to main content

Table 2 Patient characteristics (N = 211)

From: Effects of FGFR gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-docetaxel-based chemotherapy in breast cancer patients

 

Mean ± SD

N (%)

Age at diagnosis (years)

54.278 ± 10.163

 

Menopausal state

 premenopausal

 

63 (29.9)

 postmenopausal

 

148 (70.1)

Age at postmenopause (years)

52.367 ± 8.132

 

Height (cm)

159.672 ± 5.369

 

Weight (kg)

62.483 ± 8.859

 

BMI (kg.m−2)

24.114 ± 3.156

 

Parity

 

194 (91.9)

  1. BMI body mass index